At the news
? NEUTRALIMPACT 3/10 6-K filed May 28, 2026 at 10:52 ET
Pharming Group N.V. filed a 6-K reporting the results of its 2026 Annual General Meeting of Shareholders, where shareholders approved all proposals including the appointment of KPMG Accountants N.V. as the new external auditor for 2026-2028, replacing Deloitte. The filing also notes the renewal of authorizations for the Board to issue and repurchase shares. No financial results or material operational updates were disclosed.
- Shareholders approved all AGM proposals on May 28, 2026.
- KPMG Accountants N.V. appointed as external auditor for fiscal years 2026-2028, replacing Deloitte.
- Deloitte's reports for 2024 and 2025 contained no adverse opinion or disclaimer of opinion.
- No disagreements or reportable events occurred between the company and Deloitte during the relevant periods, except for previously disclosed material weaknesses in internal control over financial reporting.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access